Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models-Reference-Cited by-同舟云学术

Trastuzumab in combination with paclitaxel enhances antitumor activity by promoting apoptosis in human epidermal growth factor receptor 2-positive trastuzumab-resistant gastric cancer xenograft models

Published:2020-03 Issue:3 Volume:31 Page:241-250
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Shu Sei,Yamashita-Kashima Yoriko,Yanagisawa Mieko,Nakanishi Hayao,Kodera Yasuhiro,Harada Naoki,Yoshimura Yasushi

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference45 articles.

1. Treatment of HER2-positive breast cancer: current status and future perspectives.;Arteaga;Nat Rev Clin Oncol,2011

2. Untangling the erbb signalling network.;Yarden;Nat Rev Mol Cell Biol,2001

3. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target.;Gravalos;Ann Oncol,2008

4. The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.;Ross;Stem Cells,1998

5. HER2 status in colorectal cancer: its clinical significance and the relationship between HER2 gene amplification and expression.;Seo;Plos One,2014

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paclitaxel and its semi-synthetic derivatives: comprehensive insights into chemical structure, mechanisms of action, and anticancer properties;European Journal of Medical Research;2024-01-30

2. Patient-derived tumor models in cancer research: Evaluation of the oncostatic effects of melatonin;Biomedicine & Pharmacotherapy;2023-11

3. Patient-Derived Xenograft: A More Standard “Avatar” Model in Preclinical Studies of Gastric Cancer;Frontiers in Oncology;2022-05-19

4. Chemotherapeutic Protocols for the Treatment of Breast Cancer;Chemotherapy Protocols and Infusion Sequence;2022

5. THE EFFECT OF TP ONE WEEK REGIMEN COMBINED WITH RADIOTHERAPY ON THE CLINICAL EFFICACY AND POSTOPERATIVE COMPLICATIONS OF STAGE III ESOPHAGEAL GASTRIC JUNCTION ADENOCARCINOMA;ACTA MEDICA MEDITERR;2021